1McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage Ⅲ and stage Ⅳ ovarian cancer [J]. N Engl J Med, 1996,334 (1):1-6. 被引量：1
2Bookman MA,Greer BE,Ozols RF. Optimal therapy of advanced ovarian cancer: carhoplatin and paclitaxel vs cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5 [J]. Int J Gynecol Cancer, 2003, 13(6) :735-740. 被引量：1
3Pfisterer J, Weber B, Reuss A, et al. Randomized phase Ⅲ trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO [J]. J Natl Cancer Inst, 2006,98(15) : 1036-1045. 被引量：1
4Markman M, Liu PY, Wilczynski S, et al. Phase Ⅲ randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxelbased chemotherapy: a Southwest Oncology Group and Gynecologic Oneology Group trial [J]. J Clin Oncol, 2003,21 (13) : 2460-2465. 被引量：1
5De Placido S, Scambia G, Di Vagno G, et al. Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study [J]. J Clin Oncol,2004,22(13):2635-3642. 被引量：1
6Alberts DS, Liu PY, Hannigan EV, et al. Intraperitoneal cisplatin plus intravenous cyelophosphamide versus intravenous cisplatln plus intravenous cyclophosphamide for stage Ⅲ ovarian cancer [J]. N Engl J Med, 1996,335(26) : 1950-1955. 被引量：1
7Markman M,Bundy BN,Alberts DS,et al. Phase Ⅲ trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage Ⅲ ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group [J]. J Clin Oncol,2001, 19(4) : 1001 - 1007. 被引量：1
8Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J]. N Engl J Med,2006,354(1):34-43. 被引量：1
